Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.

Wang YX, Zhao L, Wang XY, Liu CM, Yu SG.

Endocrine. 2012 Jun;41(3):526-31. doi: 10.1007/s12020-011-9582-y. Epub 2011 Dec 23.

PMID:
22194161
2.

Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.

Zhao L, Wang YX, Xi M, Liu SL, Zhang P, Luo LL, Liu MZ.

Int J Clin Exp Pathol. 2015 May 1;8(5):5753-60. eCollection 2015.

3.

[Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].

Liang J, Li Y, Wang N.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Apr;25(2):183-6. Chinese.

PMID:
18393242
4.

Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.

Wang YX, Zhao L, Wang XY, Liu CM, Yu SG.

Med Oncol. 2012 Dec;29(4):2445-51. doi: 10.1007/s12032-011-0121-8. Epub 2011 Nov 26.

PMID:
22120515
5.

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.

Li HC, Albert JM, Shinohara ET, Cai Q, Freyer A, Cai H, Cao C, Wang Z, Kataoka N, Teng M, Zheng W, Lu B.

Urol Oncol. 2006 Nov-Dec;24(6):496-502.

PMID:
17138130
6.

The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.

Wang YX, Li ML, Yu SG, Liu CM, Han Y, Wang XY.

Pathol Res Pract. 2013 Mar;209(3):151-4. doi: 10.1016/j.prp.2013.01.004. Epub 2013 Feb 12.

PMID:
23414714
7.

[Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].

Zhang XF, Wang YM, Wang R, Wei LZ, Li Y, Guo W, Wang N, Zhang JH.

Ai Zheng. 2005 May;24(5):513-9. Chinese.

PMID:
15890089
8.

Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.

Zhang XF, Wang YM, Ge H, Cao YY, Chen ZF, Wen DG, Guo W, Wang N, Li Y, Zhang JH.

Dis Esophagus. 2008;21(1):21-9. doi: 10.1111/j.1442-2050.2007.00724.x.

PMID:
18197935
9.

E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.

Li Y, Liang J, Kang S, Dong Z, Wang N, Xing H, Zhou R, Li X, Zhao X.

Gynecol Oncol. 2008 Feb;108(2):409-14. Epub 2007 Nov 26.

PMID:
18035404
10.

Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.

Yuan K, Huo M, Sun Y, Wu H, Chen H, Wang Y, Fu R.

Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12.

PMID:
26264616
11.

Association of E-cadherin single nucleotide polymorphisms with the increased risk of endometriosis in Indian women.

Govatati S, Tangudu NK, Deenadayal M, Chakravarty B, Shivaji S, Bhanoori M.

Mol Hum Reprod. 2012 May;18(5):280-7. doi: 10.1093/molehr/gar079. Epub 2011 Dec 19.

PMID:
22184339
12.

CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.

Zhan Z, Wu J, Zhang JF, Yang YP, Tong S, Zhang CB, Li J, Yang XW, Dong W.

Mol Biol Rep. 2012 Aug;39(8):8107-13. doi: 10.1007/s11033-012-1658-0. Epub 2012 Apr 26.

PMID:
22535324
13.

Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.

Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, Wang Y, Wang X, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC.

J Med Genet. 2013 Oct;50(10):689-95. doi: 10.1136/jmedgenet-2013-101687. Epub 2013 Jul 11.

PMID:
23847140
14.

CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.

Chen B, Zhou Y, Yang P, Liu L, Qin XP, Wu XT.

Cytokine. 2011 Aug;55(2):266-73. doi: 10.1016/j.cyto.2011.04.008. Epub 2011 May 12.

PMID:
21570316
15.

Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.

Park SW, Kim MK, Kwon KH, Kim J.

Int J Immunogenet. 2012 Dec;39(6):501-7. doi: 10.1111/j.1744-313X.2012.01125.x. Epub 2012 May 18.

PMID:
22594576
16.

Association of three single nucleotide polymorphisms of the E-cadherin gene with endometriosis in a Chinese population.

Shan K, Xiao-Wei M, Na W, Xiu-Feng Z, Deng-Gui W, Wei G, Zheng-Mao Z, Yan L.

Reproduction. 2007 Aug;134(2):373-8.

17.

Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis.

Wei WJ, Wang YL, Li DS, Wang Y, Wang XF, Zhu YX, Yang YJ, Wang ZY, Ma YY, Wu Y, Jin L, Ji QH, Wang JC.

PLoS One. 2013;8(2):e56638. doi: 10.1371/journal.pone.0056638. Epub 2013 Feb 22.

18.

Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.

Chien MH, Yeh KT, Li YC, Hsieh YH, Lin CH, Weng MS, Kuo WH, Yang SF.

J Surg Oncol. 2011 Sep 1;104(3):299-304. doi: 10.1002/jso.21929. Epub 2011 Apr 1.

PMID:
21462191
19.

Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?

Ai L, Yu Y, Liu X, Wang C, Shi J, Sun H, Yu Q.

Front Med. 2014 Mar;8(1):113-7. doi: 10.1007/s11684-014-0310-x. Epub 2014 Jan 23.

PMID:
24452548
20.

Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population.

Ma ZB, Li K, Wang J, Guo GH.

Med Oncol. 2013;30(3):668. doi: 10.1007/s12032-013-0668-7. Epub 2013 Jul 20.

PMID:
23873015

Supplemental Content

Support Center